Antituberculous medication in ambulatory care – Related resources
22.09.2014 • Sonuncu dəyişiklik 08.01.2013
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
- There is insufficient evidence to assess the effectiveness of steroids in tuberculous pleural effusion .
Relapse rates are slightly higher in antituberculous regimens lasting less than six months compared to longer regimens .
- Rifabutin- and rifampicin-containing regimens appear not to differ in terms of efficacy in the treatment of pulmonary tuberculosis .
- The provision of free food, high-energy nutritional products or micronutrient supplementation for people being treated for active tuberculosis may have no effect on the treatment outcome .
Isoniazid prophylaxis appears to reduce tuberculosis incidence and mortality in HIV-infected children living in areas of high TB prevalence and not receiving antiretroviral therapy .
Clinical guidelines
Tuberculosis: NICE guideline. CG117, 23 March 2011
Literature
- Grant A, Gothard P, Thwaites G. Managing drug resistant tuberculosis. BMJ 2008 Aug 28;337():a1110.
- Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007 Dec 15;370(9604):2030-43.
- Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998 Jul;53(7):536-48.